Trastuzumab Active Not Recruiting Phase 2 Trials for Metastatic Breast Cancer (MBC) Treatment

Indications	Status	Purpose	Phase
DBCOND0032947 (Metastatic Breast Cancer (MBC))	Active Not Recruiting	Treatment	2

clinicaltrials.gov Identifier	Title	Drugs
NCT01835236	Trastuzumab & Pertuzumab Followed by T-DM1 in MBC	Pertuzumab (DB06366) Paclitaxel (DB01229) Vinorelbine (DB00361) Trastuzumab emtansine (DB05773) Trastuzumab (DB00072)
NCT00431704	VinCaT: Vinorelbine, Carboplatin and Trastuzumab in Advanced Her-2 Positive Breast Cancer	Vinorelbine (DB00361) Carboplatin (DB00958) Trastuzumab (DB00072)
NCT02536339	Pertuzumab With High-Dose Trastuzumab in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer (MBC) With Central Nervous System (CNS) Progression Post-Radiotherapy	Pertuzumab (DB06366) Trastuzumab (DB00072)